Literature DB >> 8338340

Devic's neuromyelitis optica: a clinicopathological study of 8 patients.

R N Mandler1, L E Davis, D R Jeffery, M Kornfeld.   

Abstract

We report the clinical, imaging, and laboratory features of 8 patients with Devic's neuromyelitis optica. All patients had severe myelopathy and optic neuritis. In no patient was the brain, the brainstem, or the cerebellum affected, even after several years of disease. Various immunosuppressive treatments failed to benefit the patients, 5 of whom died. Autopsies of these 5 patients demonstrated a severe necrotizing myelopathy with thickening of blood vessel walls and no lymphocyte infiltrates. In the appropriate clinical setting, the lack of white matter abnormalities demonstrated by magnetic resonance imaging of the head facilitates the recognition of Devic's syndrome during life. Inasmuch as Devic's myelopathy is necrotizing, rather than demyelinating, the prognosis of this syndrome is poor.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8338340     DOI: 10.1002/ana.410340211

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  64 in total

1.  Diffusion tensor imaging in the assessment of normal-appearing brain tissue damage in relapsing neuromyelitis optica.

Authors:  C S Yu; F C Lin; K C Li; T Z Jiang; C Z Zhu; W Qin; H Sun; P Chan
Journal:  AJNR Am J Neuroradiol       Date:  2006-05       Impact factor: 3.825

2.  Clinical profile of simultaneous bilateral optic neuritis in adults.

Authors:  J de la Cruz; M J Kupersmith
Journal:  Br J Ophthalmol       Date:  2006-05       Impact factor: 4.638

3.  Immune agents for the treatment of Devic's neuromyelitis optica.

Authors:  R Bergamaschi
Journal:  Neurol Sci       Date:  2007-10       Impact factor: 3.307

4.  Preferential spinal central gray matter involvement in neuromyelitis optica. An MRI study.

Authors:  M Nakamura; I Miyazawa; K Fujihara; I Nakashima; T Misu; S Watanabe; T Takahashi; Y Itoyama
Journal:  J Neurol       Date:  2008-02-04       Impact factor: 4.849

5.  Development of extensive brain lesions following interferon beta therapy in relapsing neuromyelitis optica and longitudinally extensive myelitis.

Authors:  Yuko Shimizu; Kazumasa Yokoyama; Tatsuro Misu; Toshiyuki Takahashi; Kazuo Fujihara; Seiji Kikuchi; Yasuto Itoyama; Makoto Iwata
Journal:  J Neurol       Date:  2007-11-21       Impact factor: 4.849

6.  An epidemiological study of neuromyelitis optica in Cuba.

Authors:  Jose A Cabrera-Gómez; John F Kurtzke; Alina González-Quevedo; R Lara-Rodríguez
Journal:  J Neurol       Date:  2009-02-09       Impact factor: 4.849

7.  Optic neuromyelitis syndrome in Brazilian patients.

Authors:  R M Papais-Alvarenga; C M Miranda-Santos; M Puccioni-Sohler; A M V de Almeida; S Oliveira; C A Basilio De Oliveira; H Alvarenga; C M Poser
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-10       Impact factor: 10.154

8.  Visualization of inflammation and demyelination in 2D2 transgenic mice with rodent MRI.

Authors:  Jordan C Bell; Qingwei Liu; Yan Gan; Qiang Liu; Yaou Liu; Fu-Dong Shi; Gregory H Turner
Journal:  J Neuroimmunol       Date:  2013-09-18       Impact factor: 3.478

Review 9.  The pathological spectrum of CNS inflammatory demyelinating diseases.

Authors:  Wei Hu; Claudia F Lucchinetti
Journal:  Semin Immunopathol       Date:  2009-09-25       Impact factor: 9.623

10.  Subacute sclerosing panencephalitis presenting as neuromyelitis optica.

Authors:  Tushar Premraj Raut; Maneesh Kumar Singh; Ravindra Kumar Garg; Pravin Umakant Naphade
Journal:  BMJ Case Rep       Date:  2012-12-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.